Faculty

Institution

Unit

Venue

Powel Brown

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Clinical Cancer Prevention, 1515 Holcombe Blvd. Unit 1360

Department Of Clinical Effectiveness

Division Of Cancer Prevention And Population Sciences

Division Of Medical Oncology

The University of Texas MD Anderson Cancer Center

NonePowel Brown is currently serving as a Clinical Cancer Prevention, 1515 Holcombe Blvd. Unit 1360 faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Powel Brown

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

breast cancer cancer research oncology cancer biology tumor biology molecular biology pharmacology cancer prevention oncogenes medicinal research breast oncology cancer cells cancer treatment cell biology molecular cancer clinical research cancer discovery medicine cancer care cancer growth cancer genetics gene expression preventive medicine cancer genomics therapeutic targets tumor targeting transcription factors tumor suppressors enzyme inhibition cellular therapy mammary gland anti-cancer agents cancer imaging cell death disease prevention gynecologic oncology leukemia endocrine-related cancers chemoprevention strategies cancer management cancer risk molecular cell biology apoptosis hormonal receptor pharmacotherapy endocrine oncology breast cancer cells er-negative breast cancer mammalian biology inhibitory activity therapeutic efficacy prevention science breast cancer prevention gene function drug targeting treatment effects estrogen receptor high risk clinical evidence transcription regulation receptor tyrosine kinases health prevention breast imaging prognostic biomarkers receptor (biochemistry) malignant breast cells aromatase inhibitors critical regulator preventive therapy transgenic mice rxr-selective retinoid cell cycle arrest premalignant lesions retinoid receptors combination chemoprevention phase ib

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 963: Preclinical Testing of A2B Adenosine Receptor Inhibitor Psb1115 for Pancreatic Cancer Immunoprevention. Cancer Research (2026)

immunologypreclinical testingabstract 963pharmacologycancer researchmolecular cancerpancreatic cancercancer immunotherapypancreatic cancer immunopreventiononcologypancreatic surgerycancer cellsmedicinal research

Data From Targeting the Rxr Pathway for the Prevention of Triple-Negative Breast Cancer. (2026)

carcinogenesismetastasiscancer researchmolecular cancerradiation oncologysystems biologycancer discoverytherapeutic targetsbreast canceroncogenescancer cellstumor microenvironmentcancer letterjama oncologymedicinal researchtumor biologycell biology

Nous-209 Neoantigen Vaccine for Cancer Prevention in Lynch Syndrome Carriers: A Phase 1B/2 Trial. Nature Medicine (2026)

immunologyvaccinesvaccine trialslynch syndrome carrierscancer researchmolecular cancercancer discoverycancer preventionmolecular diagnosticsoncologynous-209 neoantigen vaccinevaccinationpathologyexperimental medicinetherapeutic vaccinesimmunotherapy

Supplemental Figure S6 From Targeting the Rxr Pathway for the Prevention of Triple-Negative Breast Cancer. (2026)

immunologycarcinogenesismetastasiscancer researchmolecular cancerradiation oncologycancer discoverytherapeutic targetsbreast canceroncogenescancer cellstumor microenvironmentcancer letterjama oncologymedicinal researchtumor biologycell biology

Supplemental Figure S8 From Targeting the Rxr Pathway for the Prevention of Triple-Negative Breast Cancer. (2026)

immunologytriple-negative breast cancertherapeutic targetsbreast oncologybreast cancerrxr pathwayoncogenescancer cellscancer biologytumor biologysupplemental figure s8cell biology

1336 Final Ph1B/2 Results for Nous-209 Monotherapy in Lynch Syndrome Carriers: Annual Revaccination Boosts T Cell Immunity Informing Future Cancer Interception Strategies. (2025)

immunologyvaccinesvaccine trialslynch syndrome carriersnous-209 monotherapyradiation oncologyimmune checkpoint inhibitorsnovel therapiesfinal ph1b/2 resultscancer immunotherapyoncologyimmune responsesimmunomodulationcancer letterimmunity (medicine)cellular therapytherapeutic vaccinesimmunotherapy

Abstract 6332: Targeting Parp for the Prevention of Brca1-Deficient Triple-Negative Breast Cancers. Cancer Research (2025)

Amanda LanierJohn CliffordJamal HillDarian ColemanCassandra MoyerAlejandro ContrerasMark AlbertellaAnna StaniszewskaAndrew ReynoldsShizuko SeiPowel BrownAbhijit Mazumdar

cancer managementcancer researchcancer preventionbreast canceroncologycancer treatmenthealth sciencesbreast oncology

Abstract 6427: Nous-209 Off-The-Shelf Neoantigen Immunotherapy Induces Robust Neoantigen T Cell Response With the Potential to Intercept Cancer in Lynch Syndrome Carriers. Cancer Research (2025)

Jason WillisAnna Morena D'AliseMichael J. HallMarcia Cruz-CorreaGregory E. IdosSelvi ThirumurthiVeroushka BallesterGuido LeoniIrene GarziaLaura AntonucciLorenzo De MarcoElisa MicarelliSven GogovWenli DongJ. Jack LeeLana A. VornikAraceli Garcia-GonzalezLaura Reyes-UribeEllen RichmondAsad UmarPowel H. BrownLuz Maria RodriguezElisa ScarselliEduardo Vilar

immunologylynch syndrome carrierscancer researchimmune checkpoint inhibitorsnovel therapiescancer immunotherapytherapeutic targetsoncologycancer treatmentcancer biologyspecific resistanceimmunotherapy

Abstract P1-05-03: Serum and Breast Tissue Biomarker Changes Induced by Atorvastatin in Women at Increased Risk for Breast Cancer. Clinical Cancer Research (2025)

dyslipidemiaclinical lipidologypharmacologybiomarkersabstract p1-05-03cancer researchclinical biochemistrybreast cancergynecologyhealth scienceswomen's healthbreast oncology

Abstract P2-02-10: Inhibition of the Kif11 Mitotic Protein Kills Tp53-Mutant Triple-Negative Breast Cancer Cells. Clinical Cancer Research (2025)

abstract p2-02-10cell deathkif11 mitotic proteincell signalingtumor suppressorsmolecular cell biologybreast cancermolecular biologyoncogenescancer cellscancer biologytumor biologycell biology

1
2
3
4
5
30
10 / page

Powel Brown

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Clinical Cancer Prevention, 1515 Holcombe Blvd. Unit 1360

Department Of Clinical Effectiveness

Division Of Cancer Prevention And Population Sciences

Division Of Medical Oncology

The University of Texas MD Anderson Cancer Center

NonePowel Brown is currently serving as a Clinical Cancer Prevention, 1515 Holcombe Blvd. Unit 1360 faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Powel Brown

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 963: Preclinical Testing of A2B Adenosine Receptor Inhibitor Psb1115 for Pancreatic Cancer Immunoprevention. Cancer Research (2026)

Data From Targeting the Rxr Pathway for the Prevention of Triple-Negative Breast Cancer. (2026)

Nous-209 Neoantigen Vaccine for Cancer Prevention in Lynch Syndrome Carriers: A Phase 1B/2 Trial. Nature Medicine (2026)

Supplemental Figure S6 From Targeting the Rxr Pathway for the Prevention of Triple-Negative Breast Cancer. (2026)

Supplemental Figure S8 From Targeting the Rxr Pathway for the Prevention of Triple-Negative Breast Cancer. (2026)

immunologytriple-negative breast cancertherapeutic targetsbreast oncologybreast cancerrxr pathwayoncogenescancer cellscancer biologytumor biologysupplemental figure s8cell biology

1336 Final Ph1B/2 Results for Nous-209 Monotherapy in Lynch Syndrome Carriers: Annual Revaccination Boosts T Cell Immunity Informing Future Cancer Interception Strategies. (2025)

Abstract 6332: Targeting Parp for the Prevention of Brca1-Deficient Triple-Negative Breast Cancers. Cancer Research (2025)

Amanda LanierJohn CliffordJamal HillDarian ColemanCassandra MoyerAlejandro ContrerasMark AlbertellaAnna StaniszewskaAndrew ReynoldsShizuko SeiPowel BrownAbhijit Mazumdar

cancer managementcancer researchcancer preventionbreast canceroncologycancer treatmenthealth sciencesbreast oncology

Abstract 6427: Nous-209 Off-The-Shelf Neoantigen Immunotherapy Induces Robust Neoantigen T Cell Response With the Potential to Intercept Cancer in Lynch Syndrome Carriers. Cancer Research (2025)

Abstract P1-05-03: Serum and Breast Tissue Biomarker Changes Induced by Atorvastatin in Women at Increased Risk for Breast Cancer. Clinical Cancer Research (2025)

dyslipidemiaclinical lipidologypharmacologybiomarkersabstract p1-05-03cancer researchclinical biochemistrybreast cancergynecologyhealth scienceswomen's healthbreast oncology

Abstract P2-02-10: Inhibition of the Kif11 Mitotic Protein Kills Tp53-Mutant Triple-Negative Breast Cancer Cells. Clinical Cancer Research (2025)

abstract p2-02-10cell deathkif11 mitotic proteincell signalingtumor suppressorsmolecular cell biologybreast cancermolecular biologyoncogenescancer cellscancer biologytumor biologycell biology

1
2
3
4
5
30
10 / page